Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Integrating Next Generation Sequencing for Treatment of Surgical Site Infection After Fracture Fixation: A Multicenter Randomized Control Trial

NCT07458230 is registered in ClinicalTrials.gov with Johns Hopkins Bloomberg School of Public Health as lead sponsor.

NCT NCT07458230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07458230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Integrating Next Generation Sequencing for Treatment of Surgical Site Infection After Fracture Fixation: A Multicenter Randomized Control Trial
Lead sponsor
Johns Hopkins Bloomberg School of Public Health
Phase
Phase 3
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
October 1, 2028
Enrollment
250 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

fracture fixation, next generation sequencing (ngs), surgical site infection (ssi)